Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Ontaneda

Showing results (51-60 of 193) with videos related to

Pageof 20
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical outcome measures for progressive MS trialsDaniel Ontaneda, Jeffrey A Cohen, Maria Pia Amato
JAMA Neurology|May 15, 2023
Making Sure Multiple Sclerosis Counts and Is Counted for All-An Update on Multiple Sclerosis Prevalence by Race and Ethnicity in the United StatesDalia L Rotstein, Tirisham V Gyang, Daniel Ontaneda
Journal of Neuroimmunology|August 30, 2024
Discordance of reported multiple sclerosis clinical course amongst patients and providersAlbert Aboseif, Moein Amin, Gabrielle Macaron, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2012
Metabolic syndrome in small fiber sensory neuropathyLan Zhou, Jianbo Li, Daniel Ontaneda, et al.
Journal of Neuroimmunology|December 18, 2021
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposureKarlo Toljan, Moein Amin, Amy Kunchok, et al.
Continuum (Minneapolis, Minn.)|April 2, 2026
Treatment of Multiple SclerosisEllen M Mowry, Darin T Okuda, Daniel Ontaneda
Current Opinion in Neurology|March 12, 2021
Predicting disability worsening in relapsing and progressive multiple sclerosisSarah B Simmons, Sven Schippling, Gavin Giovannoni, et al.
Journal of Neurology|October 21, 2023
Identification and management of subclinical disease activity in early multiple sclerosis: a reviewDaniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, et al.
Neurology|June 14, 2006
Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferonEli Skromne, Victor M Rivera, Daniel Ontaneda, et al.
Clinical Neurology and Neurosurgery|April 21, 2006
Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndromeLaura Ordonez, Eli Skromne, Daniel Ontaneda, et al.
Pageof 20

Showing results (51-60 of 193) with videos related to

Sort By:
Pageof 20
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 19, 2017
Clinical outcome measures for progressive MS trialsDaniel Ontaneda, Jeffrey A Cohen, Maria Pia Amato
JAMA Neurology|May 15, 2023
Making Sure Multiple Sclerosis Counts and Is Counted for All-An Update on Multiple Sclerosis Prevalence by Race and Ethnicity in the United StatesDalia L Rotstein, Tirisham V Gyang, Daniel Ontaneda
Journal of Neuroimmunology|August 30, 2024
Discordance of reported multiple sclerosis clinical course amongst patients and providersAlbert Aboseif, Moein Amin, Gabrielle Macaron, et al.
Journal of Clinical Neuromuscular Disease|February 25, 2012
Metabolic syndrome in small fiber sensory neuropathyLan Zhou, Jianbo Li, Daniel Ontaneda, et al.
Journal of Neuroimmunology|December 18, 2021
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposureKarlo Toljan, Moein Amin, Amy Kunchok, et al.
Continuum (Minneapolis, Minn.)|April 2, 2026
Treatment of Multiple SclerosisEllen M Mowry, Darin T Okuda, Daniel Ontaneda
Current Opinion in Neurology|March 12, 2021
Predicting disability worsening in relapsing and progressive multiple sclerosisSarah B Simmons, Sven Schippling, Gavin Giovannoni, et al.
Journal of Neurology|October 21, 2023
Identification and management of subclinical disease activity in early multiple sclerosis: a reviewDaniel Ontaneda, Tanuja Chitnis, Kottil Rammohan, et al.
Neurology|June 14, 2006
Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferonEli Skromne, Victor M Rivera, Daniel Ontaneda, et al.
Clinical Neurology and Neurosurgery|April 21, 2006
Multiphasic disseminated encephalomyelitis, systemic lupus erythematosus and antiphospholipid syndromeLaura Ordonez, Eli Skromne, Daniel Ontaneda, et al.
Pageof 20